EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The role of interleukin‐6 family cytokines in cancer cachexia

Samet Agca, Serkan Kir iD

The FEBS Journal · 08.07.2024

DOI: 10.1111/febs.17224 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 08.07.2024. Verfasst von Samet Agca und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Koc University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Cachexia, Interleukin-6, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Molecular Biology Organization, Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cachexia is a wasting syndrome that manifests in more than half of all cancer patients. Cancer‐associated cachexia negatively influences the survival of patients and their quality of life. It is characterized by a rapid loss of adipose and skeletal muscle tissues, which is partly mediated by inflammatory cytokines. Here, we explored the crucial roles of interleukin‐6 (IL‐6) family cytokines, including IL‐6, leukemia inhibitory factor, and oncostatin M, in the development of cancer cachexia. These cytokines have been shown to exacerbate cachexia by promoting the wasting of adipose and muscle tissues, activating mechanisms that enhance lipolysis and proteolysis. Overlapping effects of the IL‐6 family cytokines depend on janus kinase/signal transducer and activator of transcription 3 signaling. We argue that the blockade of these cytokine pathways individually may fail due to redundancy and future therapeutic approaches should target common downstream elements to yield effective clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaInterleukin-6NeoplasmsHumansSignal TransductionAnimalsSTAT3 Transcription FactorMuscle, SkeletalLeukemia Inhibitory FactorOncostatin MAdipose Tissue

Stichwörter der Autor:innen

adipose tissue wastingcancer cachexiainterleukin‐6leukemia inhibitory factormuscle atrophyoncostatin M

Substanzen

Interleukin-6STAT3 Transcription FactorLeukemia Inhibitory FactorOncostatin M

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Koc University, Istanbul, Turkey.

ORCID-Profile: Serkan Kir

Förderung

  • European Molecular Biology Organization
  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Zitieren

APA

Agca, S., & Kir, S. (2024). The role of interleukin‐6 family cytokines in cancer cachexia. The FEBS Journal. https://doi.org/10.1111/febs.17224

Vancouver

Agca S, Kir S. The role of interleukin‐6 family cytokines in cancer cachexia. The FEBS Journal. 2024. doi:10.1111/febs.17224

BibTeX
@article{Agca2024,
  author = {Agca, Samet and Kir, Serkan},
  title = {The role of interleukin‐6 family cytokines in cancer cachexia},
  journal = {The FEBS Journal},
  year = {2024},
  doi = {10.1111/febs.17224}
}
Kostenlos starten →